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Table E1: 24 
The demographics of the participants in the extension of the trial were similar to the demographics 25 
of the participants that did not participate in the extension. 26 
 Participating in the extension NOT participating in the extension 






Number of Participants, N (%) 162 (100) 189 (100) 156 (100) 127 (100) 
Sex          
   Men, N (%) 97 (60) 118 (62)  96    (62) 61 (48) 
   Women, N (%) 65 (40) 71 (38) 60 (38) 66 (52) 
Age (Years)         
   Mean (SD) 35.9 (9.61) 35.4 (9.77) 33.0 (10.2) 31.6 (8.90) 
   Median 35.0  35.0  31.5  30.0  
   [Q5%; Q95%] [22.0; 55.0] [22.0; 56.0] [20.0 - 53.0] [21.0 - 49.0] 
Ethnic Origin         
   Caucasian, N (%) 155 (96) 180 (95) 153 (98) 119 (94) 
   Other, N (%) 7 (4) 9 (5) 3 (2) 8 (6) 
Severity of Grass Pollen Allergy         
   Moderate, N (%) 71 (44) 72 (38) 73 (47) 65 (51) 
   Severe, N (%) 91 (56) 117 (62) 83 (53) 62 (49) 
Grass Pollen Allergy (Years):         
   N 160  187  156  126  
   Mean (SD) 17.4 (10.4) 18.1 (10.4) 14.7  (10.6) 13.6 (9.18) 
   Median 17.0  17.0  13.5  11.5  
   [Q5%; Q95%] [3.00; 37.5] [3.00; 36.0] [2.00 - 34.0] [2.00 - 30.0] 
N: number of participants; %: percent of group; SD: standard deviation 
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